All Updates

All Updates

icon
Filter
Partnerships
Psylo partners with University of Sydney to advance neuro-drug development
Psychedelic Medicine
Jun 27, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Psychedelic Medicine

Psychedelic Medicine

Jun 27, 2024

Psylo partners with University of Sydney to advance neuro-drug development

Partnerships

  • Psylo, a preclinical-stage biotechnology company, has partnered with the University of Sydney's Brain and Mind Centre to develop treatments for psychiatric and neurological disorders using advanced AI.

  • This collaboration will leverage the machine-learning behavioral analysis technology of Dr. Nick Everett, a research fellow at the University of Sydney.

  • This technology uses high-speed cameras and advanced data interpretation to anticipate behavior and assess the potential therapeutic properties of new drugs. Psylo will incorporate this technology to improve its drug development process.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.